Literature DB >> 4031063

Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.

W F Beltz, Y A Kesäniemi, B V Howard, S M Grundy.   

Abstract

To quantify more precisely the metabolism of apolipoprotein B (apo B) in human beings, an integrated model was developed for the analysis of the isotope kinetics of apo B in very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), and low density lipoproteins (LDL). The experimental basis for model development was a series of 30 triple-isotope studies in which patients received autologous 131I-VLDL, 125I-IDL, and [3H]glycerol as a precursor of VLDL triglycerides. The currently proposed model contains the following components: (a) a VLDL delipidation cascade that has a variable number of subcompartments, (b) a slowly catabolized pool of VLDL, (c) an IDL compartment consisting of two closely connected subcompartments, one of which is outside the immediate circulation, and (d) a two-compartment subsystem for LDL. Because mass data indicate that not all VLDL were converted to LDL, the model allows for irreversible removal of apo B from VLDL (or IDL) subsystems. It accounts for apparent "direct" input of LDL by postulating an early, rapidly metabolized compartment of VLDL that is converted directly to IDL. The model appears to be consistent with specific activity curves from the current triple-isotope studies and with present concepts of lipoprotein physiology; it also can be used to quantify pathways of lipoprotein apo B transport in normal and abnormal states.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031063      PMCID: PMC423863          DOI: 10.1172/JCI112009

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Low-density lipoprotein turnover studies in man. Evaluation of the integrated rate equations method, use of a whole-body radioactivity counter, and the problem of partial denaturation.

Authors:  G D Calvert; H M James
Journal:  Clin Sci (Lond)       Date:  1979-01       Impact factor: 6.124

2.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

4.  On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein.

Authors:  S Eisenberg; D W Bilheimer; R I Levy; F T Lindgren
Journal:  Biochim Biophys Acta       Date:  1973-12-20

Review 5.  Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.

Authors:  M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

6.  Synthesis of plasma lipoproteins by the isolated perfused liver from the fasted and fed pig.

Authors:  N Nakaya; B H Chung; O D Taunton
Journal:  J Biol Chem       Date:  1977-08-10       Impact factor: 5.157

7.  Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.

Authors:  J Melish; N A Le; H Ginsberg; D Steinberg; W V Brown
Journal:  Am J Physiol       Date:  1980-11

8.  Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients.

Authors:  C J Packard; J L Third; J Shepherd; A R Lorimer; H G Morgan; T D Lawrie
Journal:  Metabolism       Date:  1976-09       Impact factor: 8.694

9.  Influence of obesity on the metabolism of apolipoprotein B in humans.

Authors:  G Egusa; W F Beltz; S M Grundy; B V Howard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL.

Authors:  W R Fisher; L A Zech; P Bardalaye; G Warmke; M Berman
Journal:  J Lipid Res       Date:  1980-08       Impact factor: 5.922

View more
  23 in total

1.  Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

Authors:  J S Cohn; D A Wagner; S D Cohn; J S Millar; E J Schaefer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat.

Authors:  Chunyu Zheng; Katsunori Ikewaki; Brian W Walsh; Frank M Sacks
Journal:  J Lipid Res       Date:  2006-05-09       Impact factor: 5.922

3.  Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

Authors:  B Teng; A D Sniderman; A K Soutar; G R Thompson
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

4.  Basal and insulin-regulated VLDL1 and VLDL2 kinetics in men with type 2 diabetes.

Authors:  Rakel F Johansen; Esben Søndergaard; Lars Peter Sørensen; Anne Grethe Jurik; Jens S Christiansen; Søren Nielsen
Journal:  Diabetologia       Date:  2016-01-19       Impact factor: 10.122

5.  Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.

Authors:  W G Abbott; B Swinburn; G Ruotolo; H Hara; L Patti; I Harper; S M Grundy; B V Howard
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Regulation of very low density lipoprotein apo B metabolism by dietary fat saturation and chain length in the guinea pig.

Authors:  G Abdel-Fattah; M L Fernandez; D J McNamara
Journal:  Lipids       Date:  1998-01       Impact factor: 1.880

7.  Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size.

Authors:  Daniël B van Schalkwijk; Albert A de Graaf; Ben van Ommen; Kees van Bochove; Patrick C N Rensen; Louis M Havekes; Niek C A van de Pas; Huub C J Hoefsloot; Jan van der Greef; Andreas P Freidig
Journal:  J Lipid Res       Date:  2009-06-10       Impact factor: 5.922

8.  Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.

Authors:  H N Ginsberg; N A Le; M P Short; R Ramakrishnan; R J Desnick
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

9.  Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

Authors:  Y A Kesäniemi; W F Beltz; S M Grundy
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia.

Authors:  K G Parhofer; P H Barrett; J Dunn; G Schonfeld
Journal:  Clin Investig       Date:  1993-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.